Skip to main content

Table 4 Frequency of complications reported in the six age ranges

From: Safety reporting on implantation of autologous adipose tissue-derived stem cells with platelet-rich plasma into human articular joints

Age range (years)

Percentage of treated joints

 

Pain and swelling with improvement

Infection

Neurologic

Tumor

Tendonitis/ Tenosinovitis

Skin

18 ~ 29

3

-

-

-

-

-

30 ~ 39

5

-

-

-

-

-

40 ~ 49

10

-

-

-

2

-

50 ~ 59

10

-

-

-

5

-

60 ~ 69

4

-

1

-

10

1

70 ~ 80

5

-

-

-

5

-

  1. -: no complication.